Conservative treatment of early endometrial cancer

Journal of Cellular Physiology

Volumn 228, Issue 6, 2013, Pages 1154-1158

  Bovicelli, Alessandro ^a,b   D'Andrilli, Giuseppina ^a   Giordano, Antonio ^a,c   De Iaco, Pierandrea ^b  

^a Temple University   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PROGESTERONE; PROGESTERONE RECEPTOR; TUMOR MARKER;

CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CONSERVATIVE TREATMENT; DRUG EFFICACY; DRUG MEGADOSE; EARLY CANCER; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FOLLOW UP; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INFERTILITY THERAPY; INTRAUTERINE CONTRACEPTIVE DEVICE; PATIENT SELECTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANTINEOPLASTIC AGENTS, HORMONAL; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY; FERTILITY PRESERVATION; HUMANS; PATIENT SELECTION; PROGESTINS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84874205804     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24292     Document Type: Review

References (23)

1. Chiva de Agustin L, Lapuente Sastre F, Corraliza Galan V, Granados Galainena L, Gonzalez Martin A, Gonzalez Cortijo L, Carballo Gonzalez N. 2008. Conservative management of patients with early endometrial carcinoma: A systematic review. Clin Transl Oncol 10: 155-162.
2. Dursun P, Erkanli S, Guzel AB, Gultekin M, Tarhan NC, Altundag O, Demirkiran F, Bese T, Yildirim Y, Bozdag G, Yarali H, Simsek T, Ozcelik B, Ortaç F, Taskin S, Guvenal T, Ozgul N, Haberal A, Vardar MA, Dede M, Yenen M, Altintas A, Arvas M, Ayhan A. 2012. A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer. Int J Gynaecol Obstet 119: 270-273.
3. Farhi DC, Nosanchuk J, Silverberg SG. 1986. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 68: 741-745.
4. Gadducci A, Spirito N, Baroni E, Tana R, Genazzani AR. 2009. The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option. Gynecol Endocrinol 25: 683-691.
5. Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. 2012. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: A systematic review and metaanalysis. Am J Obstet Gynecol 207: 266 e1-266 e12.
6. Gallup DG, Stock RJ. 1984. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 64: 417-420.
7. Hahn HS, Yoon SG, Hong JS, Hong SR, Park SJ, Lim JY, Kwon YS, Lee IH, Lim KT, Lee KH, Shim JU, Mok JE, Kim TJ. 2009. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer 19: 1068-1073.
8. Kalogiannidis I, Agorastos T. 2011. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma. J Obstet Gynaecol 31: 13-17.
9. Kim MK, Yoon BS, Park H, Seong SJ, Chung HH, Kim JW, Kang SB. 2011. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: Pilot study. Int J Gynecol Cancer 21: 673-677.
10. Koskas M, Azria E, Walker F, Luton D, Madelenat P, Yazbeck C. 2012. Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility. Anticancer Res 32: 1037-1043.
11. Kurman RJ, Kaminski PF, Norris HJ. 1985. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56: 403-412.
12. Laurelli G, Di Vagno G, Scaffa C, Losito S, Del Giudice M, Greggi S. 2011. Conservative treatment of early endometrial cancer: Preliminary results of a pilot study. Gynecol Oncol 120: 43-46.
13. Mao Y, Wan X, Chen Y, Lv W, Xie X. 2010. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma. Fertil Steril 93: 283-285.
14. Masciullo V, Amadio G, Lo Russo D, Raimondo I, Giordano A, Scambia G. 2010. Controversies in the management of endometrial cancer. Obstet Gynecol Int 2010: 638165.
15. Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, Scambia G. 2010. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril 93: 1286-1289.
16. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. 2002. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 186: 651-657.
17. Nyholm HC, Nielsen AL, Norup P. 1993. Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: Comparison of clinical and histopathological characteristics. Gynecol Oncol 49: 229-235.
18. Park H, Seok JM, Yoon BS, Seong SJ, Kim JY, Shim JY, Park CT. 2012. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium. Arch Gynecol Obstet 285: 473-478.
19. Perri T, Korach J, Gotlieb WH, Beiner M, Meirow D, Friedman E, Ferenczy A, Ben-Baruch G. 2011. Prolonged conservative treatment of endometrial cancer patients: More than 1 pregnancy can be achieved. Int J Gynecol Cancer 21: 72-78.
20. Siegel R, Ward E, Brawley O, Jemal A. 2011. Cancer Statistics, 2011. CA Cancer J Clin 61: 212-236.
21. Signorelli M, Caspani G, Bonazzi C, Chiappa V, Perego P, Mangioni C. 2009. Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: A prospective single-institution experience of 21 cases. BJOG 116: 114-118.
22. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ II, Alberts D, Curtin J. 2006. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: A Gynecologic Oncology Group study. Cancer 106: 812-819.
23. Yamazawa K, Hirai M, Fujito A, Nishi H, Terauchi F, Ishikura H, Shozu M, Isaka K. 2007. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod 22: 1953-1958.